Interaction between methylphenidate, methadone and different antidepressant drugs on antinociception in mice, and possible clinical implications

Abstract

Objectives: Methylphenidate (MPH), a psychostimulant used for treatment of attention deficit hyperactivity disorder (ADHD), is widely used by patients on antidepressants and methadone maintenance treatment (MMT). Preclinical studies showed MPH to exert analgesic effects when given alone or with morphine. Methods: Using the hotplate assay on mice, we studied the interaction of acute doses of MPH with sub-threshold doses of methadone and different antidepressant medications and the interaction of increasing doses of MPH with chronic methadone. Results: Adding a sub-threshold dose of venlafaxine, desipramine or clomipramine to MPH produced significant augmentation of MPH antinociception with each medication (P < 0.05). No such interactions were found between escitalopram and acute methadone. However, addition of increasing doses of MPH to chronic methadone given for 2 weeks using ALZET osmotic mini pumps induced augmentation of the antinociceptive effect of chronic methadone exclusively at high dose of MPH (7.5 mg/kg). Conclusions: These findings may implicate the need of an excessive attention to the administration of MPH to MMT patients. The no interaction found between MPH and escitalopram may hint to the possibly safe co-administration of MPH and selective serotonin reuptake inhibitors (SSRIs) to depressed ADHD patients. Further studies are needed in order to validate these possible clinical implications.

Key words::

• Hotplate assay
• mice
• methylphenidate
• methadone
• antidepressants

Acknowledgements

This study was supported (in part) by (i) grant from The Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases at Tel-Aviv University; (ii) The Ari and Regine Aprijaskis Fund, at Tel-Aviv University, Israel.

Statement of Interest

None to declare.